Avara Pharmaceutical Services has agreed to acquire the largest sterile manufacturing facility for injectable medicines in Canada from a leading global pharmaceutical company, as part of a continuing expansion of its global footprint. “This acquisition represents our first entry into the Canadian market and further expands our sterile processing capability, which is in very high demand,” said Timothy C. Tyson, Avara’s chairman and chief executive officer. “It comes wit...